Veterinary Medicines

IZOMAST, pomata endomammaria per bovine in lattazione

Authorised
  • Cloxacillin sodium
  • Amoxicillin sodium
Download as PDF

Product identification

Medicine name:
IZOMAST, pomata endomammaria per bovine in lattazione
Active substance:
  • Cloxacillin sodium
  • Amoxicillin sodium
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cloxacillin sodium
    0.16
    gram(s)
    /
    1.00
    Syringe
  • Amoxicillin sodium
    0.16
    gram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary ointment
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Meat and offal
        12
        day
      • Milk
        96
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC26
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Izo S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Izo S.r.l.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."